Published Date: Feb-19
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report LAMEA Cardiac Pacemaker Market, published by KBV research, the LAMEA Cardiac Pacemaker Market would witness market growth of 7.8% CAGR during the forecast period (2018 – 2024).
The Brazil market dominated the LAMEA Dual-Chamber Cardiac Pacemakers Market by Country 2017, thereby; achieving a market value of $42.2 million by 2024The Argentina market is expected to witness a CAGR of 8.8% during (2018 - 2024). Additionally, The UAE market is expected to witness a CAGR of 7.6% during (2018 - 2024).
The Hospitals market would dominate the LAMEA Cardiac Pacemaker Market by End User 2024; growing at a CAGR of 7.8 % during the forecast period. The Ambulatory Surgery Centers (ASCs) market is expected to witness a CAGR of 7.4% during (2018 - 2024).
The Implantable Cardiac Pacemakers market dominated the Saudi Arabia Cardiac Pacemaker Market by Product 2017, growing at a CAGR of 7.5 % during the forecast period. The External Cardiac Pacemaker market is expected to witness highest CAGR of 8.9% during (2018 - 2024).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories (U.S.), Boston Scientific Corporation, Biotronik SE & Co. KG, Lepu Medical Technology Co ltd, Cook Medical Group, Medico S.p.A, LivaNova PL, Osypka Medical GmbH, Shree Pacetronix Ltd. and Medline Industries, Inc.
LAMEA Cardiac Pacemaker Market Segmentation
By End User
Unique Offerings from KBV Research